MedTrace Logo

Management of Warthin Tumor of Parotid Gland.

NCT05221736 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-02-03

No results posted yet for this study

Summary

Comparison between Ultrasound-Guided Ethanol Sclerotherapy (UGES) \& surgical excision in management of warthin tumor of parotid gland.

Conditions

  • Warthin's Tumor of Parotid Gland

Interventions

PROCEDURE

Ultrasound-Guided Ethanol Sclerotherapy (UGES)

Comparison between Ultrasound-Guided Ethanol Sclerotherapy (UGES) \& surgical excision in management of warthin tumor of parotid gland.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hamdan S. Abbas · Assiut University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-07-31
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05221736 on ClinicalTrials.gov